Follow the IDL Diagnostics stock price and the full management transaction log of the company, a publicly traded company based in Finland. Shares trade on the FI market, under the supervision of FIN-FSA. Operating in the Health Care sector, IDL Diagnostics has recorded 2 reports. Market capitalisation: €86.6m. The latest transaction was filed on 30 May 2026 (Purchase). Among the most active insiders: Eva Nordström. All data is openly available.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
IDL Diagnostics es una empresa enfocada en el desarrollo de soluciones de diagnóstico médico. Opera en el mercado de valores XSTO.